Biocryst Pharmaceuticals (BCRX) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-2.98
-1.94
-0.89
0.15

Details

Expected EPS
0.15418
Actual EPS
N/A
Surprise EPS
-0.15
Surprise Percent
+100%

Description

Biocryst Pharmaceuticals (BCRX) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts